Slingshot homolog-1–mediated Nrf2 sequestration tips the balance from neuroprotection to neurodegeneration in Alzheimer’s disease
Open Access
- 18 July 2023
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (30)
Abstract
Oxidative damage in the brain is one of the earliest drivers of pathology in Alzheimer’s disease (AD) and related dementias, both preceding and exacerbating clinical symptoms. In response to oxidative stress, nuclear factor erythroid 2-related factor 2 (Nrf2) is normally activated to protect the brain from oxidative damage. However, Nrf2-mediated defense against oxidative stress declines in AD, rendering the brain increasingly vulnerable to oxidative damage. Although this phenomenon has long been recognized, its mechanistic basis has been a mystery. Here, we demonstrate through in vitro and in vivo models, as well as human AD brain tissue, that Slingshot homolog-1 (SSH1) drives this effect by acting as a counterweight to neuroprotective Nrf2 in response to oxidative stress and disease. Specifically, oxidative stress-activated SSH1 suppresses nuclear Nrf2 signaling by sequestering Nrf2 complexes on actin filaments and augmenting Kelch-like ECH-associated protein 1 (Keap1)–Nrf2 interaction, independently of SSH1 phosphatase activity. We also show that Ssh1 elimination in AD models increases Nrf2 activation, which mitigates tau and amyloid-β accumulation and protects against oxidative injury, neuroinflammation, and neurodegeneration. Furthermore, loss of Ssh1 preserves normal synaptic function and transcriptomic patterns in tau P301S mice. Importantly, we also show that human AD brains exhibit highly elevated interactions of Nrf2 with both SSH1 and Keap1. Thus, we demonstrate here a unique mode of Nrf2 blockade that occurs through SSH1, which drives oxidative damage and ensuing pathogenesis in AD. Strategies to inhibit SSH1-mediated Nrf2 suppression while preserving normal SSH1 catalytic function may provide new neuroprotective therapies for AD and related dementias.Keywords
Funding Information
- HHS | NIH | National Institute on Aging (R01AG059721)
- HHS | National Institutes of Health (R01AG067741)
- HHS | National Institutes of Health (R01NS122350)
- HHS | National Institutes of Health (RF1AG053060)
- U.S. Department of Veterans Affairs (BX004680)
- U.S. Department of Veterans Affairs (I01BX005976)
- HHS | NIH | National Institute of General Medical Sciences (RM1 GM142002)
- HHS | NIH | National Institute on Aging (RO1AG066707)
- HHS | NIH | National Institute on Aging (1 U01 AG073323)
This publication has 76 references indexed in Scilit:
- Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective AutophagyMolecular Cell, 2013
- Regulation of Cofilin Activity by CaMKII and CalcineurinThe American Journal of the Medical Sciences, 2012
- ADF/Cofilin: a functional node in cell biologyTrends in Cell Biology, 2010
- Reactive Oxygen Species Regulate a Slingshot-Cofilin Activation PathwayMolecular Biology of the Cell, 2009
- Protein kinase D1 regulates cofilin-mediated F-actin reorganization and cell motility through slingshotNature Cell Biology, 2009
- Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in miceProceedings of the National Academy of Sciences, 2009
- The Antioxidant Defense System Keap1-Nrf2 Comprises a Multiple Sensing Mechanism for Responding to a Wide Range of Chemical CompoundsMolecular and Cellular Biology, 2009
- Actin filaments‐stabilizing and ‐bundling activities of cofilin‐phosphatase Slingshot‐1Genes to Cells, 2007
- A genomic screen for activators of the antioxidant response elementProceedings of the National Academy of Sciences, 2007
- Expression of Nrf2 in Neurodegenerative DiseasesJournal of Neuropathology & Experimental Neurology, 2007